semaglutide natural alternative and Weight Loss: What You Need to Know GLP-1 Alternatives and What to

A 2021 Update on the Use of Liraglutide in the Modern Treatment of Diabesity: A Narrative Review

Additional considerations: Pancreatitis has been reported with GLP-1 receptor agonists

When should I stop taking the medication or seek medical help

However: Longer-term safety data (5+ years) is still being collected Individual risk factors vary significantly Regular medical monitoring essential for ongoing safety assessment Some individuals develop side effects requiring discontinuation Long-term cardiovascular benefits observed in some trials (SELECT trial with semaglutide) Healthcare providers should regularly reassess whether continued treatment remains appropriate for individual circumstances based on ongoing benefits, risks, and patient preferences

We also thank Florian Huwyler from the Federal Institute of Technology Zurich for performing the viscosity experiments